Patients on oral anticoagulants need rapid reversal of the anticoagulant effect in case of acute bleeding or emergency surgery. Prothrombin Complex Concentrates are known to provide a fast reversal of the anticoagulant effect, with several advantages over alternatives like vitamin K or FFP.The planned clinical Phase III study is designed to provide clinically relevant data on efficacy and safety.

Treatment with any other investigational drug in the last 30 days before study entry

Less than 2 weeks of stable oral anticoagulation

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00168077

Locations

Austria

Clinical Trials Registration Coordinator

Feldkirch, Austria, 6800

Clinical Trials Registration Coordinator

Wien, Austria, 1090

Germany

Clinical Trials Registration Coordinator

Halle/Saale, Germany, 06112

Clinical Trials Registration Coordinator

Hannover, Germany, 30623

Clinical Trials Registration Coordinator

Leipzig, Germany, 04129

For information on sites in Europe, please contact our clinical research team in